Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jan;61(1):96-106.
doi: 10.1111/epi.16409. Epub 2019 Dec 11.

Responsive neurostimulation for regional neocortical epilepsy

Brandy B Ma  1 , Madeline C Fields  2 , Robert C Knowlton  1 , Edward F Chang  3 , Jerzy P Szaflarski  4 , Lara V Marcuse  2 , Vikram R Rao  1
Affiliations
Multicenter Study

Responsive neurostimulation for regional neocortical epilepsy

Brandy B Ma et al. Epilepsia. 2020 Jan.

Abstract

Objective: Surgical resection of seizure-producing brain tissue is a gold standard treatment for drug-resistant focal epilepsy. However, several patient-specific factors can preclude resective surgery, including a spatially extensive ("regional") seizure-onset zone (SOZ). For such patients, responsive neurostimulation (RNS) represents a potential treatment, but its efficacy has not been investigated in this population.

Methods: We performed a multicenter retrospective cohort study of patients (N = 30) with drug-resistant focal epilepsy and a regional neocortical SOZ delineated by intracranial monitoring who were treated with the RNS System for at least 6 months. RNS System leads were placed at least 1-cm apart over the SOZ, and most patients were treated with a lead-to-lead stimulation pathway. Five patients underwent partial resection of the SOZ concurrent with RNS System implantation. We assessed change in seizure frequency relative to preimplant baseline and evaluated correlation between clinical outcome and stimulation parameters.

Results: Median follow-up duration was 21.5 months (range 6-52). Median reduction in clinical seizure frequency was 75.5% (interquartile range [IQR] 40%-93.9%). There was no significant difference in outcome between patients treated with and without concurrent partial resection. Most patients were treated with low charge densities (1-2.5 µC/cm2 ), but charge density, interlead distance, and duration of treatment were not significantly correlated with outcome.

Significance: RNS is a feasible and effective treatment in patients with drug-resistant regional neocortical seizures. Prospective studies in larger cohorts are necessary to determine optimal lead configuration and stimulation parameters, although our results suggest that lead-to-lead stimulation and low charge density may be effective in some patients.

Keywords: drug-resistant epilepsy; RNS System; responsive neurostimulation; regional neocortical seizures.

PubMed Disclaimer

References

REFERENCES

    1. Englot DJ, Chang EF. Rates and predictors of seizure freedom in resective epilepsy surgery: an update. Neurosurg Rev. 2014;37:389-404.
    1. Kim DW, Kim HK, Lee SK, Chu K, Chung CK. Extent of neocortical resection and surgical outcome of epilepsy: Intracranial EEG analysis. Epilepsia. 2010;51:1010-7.
    1. Andrews JP, Gummadavelli A, Farooque P, Bonito J, Arencibia C, Blumenfeld H, et al. Association of seizure spread with surgical failure in epilepsy. JAMA Neurology. 2019;76:462-9.
    1. Geller EB. Responsive neurostimulation: review of clinical trials and insights into focal epilepsy. Epilepsy Behav. 2018;88S:11-20.
    1. Ma BB, Rao VR. Responsive neurostimulation: candidates and considerations. Epilepsy Behav. 2018;88:388-95.

Publication types

LinkOut - more resources